Am I a Candidate for Hand Arthritis Embolization?

Quick Answer

In published studies, hand embolization was used for adults with thumb base or finger joint osteoarthritis whose pain was at least moderate and had not improved after months of standard care. The evidence is five small uncontrolled studies, so it is an early-stage option and a careful evaluation matters.

Hand and finger embolization is a newer procedure done through a small needle or catheter in a wrist artery that aims to ease arthritis pain by briefly reducing blood flow to inflamed joint lining. Dr. Fox evaluates patients for it at our Manhattan office, and the first job of that visit is deciding whether it makes sense for you at all. This guide covers who was treated in the published studies, who was kept out, and when a different treatment is the better choice. For an overview of the procedure, start with our hand arthritis embolization page.

The short version

People treated in the published hand studies generally shared these traits, as far as the study summaries describe them:

Osteoarthritis of the thumb base or the finger joints, confirmed by a clinician and usually by X-ray.
Pain that was at least moderate, often 4 or more out of 10.
Pain that had not improved enough after months of standard care such as splints, anti-inflammatory medicine, therapy or injections.
Healthy enough circulation in the hand and wrist to allow a needle in a wrist artery (tested before treatment in the one study that describes its work-up).

If that describes you, a conversation is reasonable. It is not a first treatment, and it is not a replacement for a clear diagnosis.

How early the evidence is

You should know this before deciding whether to pursue an evaluation. As of October 2026, embolization for hand osteoarthritis rests on five small published studies with 204 patients in total. Every one is an uncontrolled case series, meaning everyone got the treatment and no one got a placebo or a comparison treatment. There is no randomized trial for the hand.

That matters because hand arthritis pain rises and falls on its own, and the American Academy of Orthopaedic Surgeons notes that some people with thumb arthritis find their symptoms ease over time with or without treatment. A before-and-after study cannot separate the effect of the procedure from that. A 2026 independent review rated embolization for finger and thumb base joints as "hypothesis-generating," and the American and European hand osteoarthritis guidelines do not mention it. Our article on what the hand embolization studies show goes through each study.

Who was included in the published studies

Because the treatment is still being studied, the clearest guide to candidacy is who the researchers chose to treat.

Study	Who was treated
Inui 2021, Tokyo, 31 patients	Thumb base arthritis at Eaton stage II or III (Eaton is an X-ray grading scale), symptoms for more than 6 months, not improved after at least 3 months of conservative therapy
Liang 2023, Taiwan, 58 patients	Finger joint arthritis pain that had not responded to medical management
Kubo 2023, Japan, 92 patients	Arthritis of the middle or end finger joints meeting American College of Rheumatology criteria, with pain of at least 4 out of 10. Mean age was 55, and 92% were women
Lee 2024, Taiwan, 9 patients	Age 40 or older, X-ray confirmed hand arthritis in one or several joints, pain above 50 on a 100-point scale, and at least 3 months of conservative treatment (injection, splint, physical therapy, anti-inflammatories or pain relievers)
Konduru 2026, North Carolina, 14 patients	Thumb base arthritis graded on the Eaton scale. This is the only US series

Notice what is missing. The one thumb-base study that states its range enrolled Eaton stage II or III only, and no study reports erosive hand osteoarthritis as a separate group, the more aggressive form with sudden swelling and redness.

Questions about your treatment options? Dr. Fox can help.

Book a Consultation

This article is part of our Embolization Guide.

Signs it may be worth discussing

You may be a reasonable person to evaluate if most of these are true:

Your diagnosis is osteoarthritis. The studies enrolled osteoarthritis only. Our guide to hand osteoarthritis causes, symptoms and diagnosis explains how it is told apart from other kinds of arthritis.
Pain is your main problem. The studies measured pain first. Stiffness, bony bumps and joint shape are a different matter, and embolization does not rebuild cartilage.
You have given standard care a real try. In the studies that state it, that meant at least 3 months.
The painful joints are the ones that were studied. That means the thumb base and the middle and end finger joints.
You accept the uncertainty. Results so far are encouraging but unproven, and about 1 in 4 patients in the largest series (92 patients) did not reach the study's definition of success at 12 months.

Who is usually not a candidate

No guideline lists formal contraindications for hand embolization. What exists are the exclusion criteria researchers wrote for their own studies. Treat the lists below as exactly that: groups that were kept out of a study, not groups proven to be harmed.

Excluded from the 2024 Taiwan study (9 patients):

Rheumatoid arthritis
Advanced hardening of the arteries
Allergy to iodinated contrast dye or to antibiotics
Infection near the treatment area
A wrist circulation test (the Barbeau test) showing poor backup blood flow to the hand

Exclusion criteria in the registration of a French safety trial (NCT06611007, 15 patients planned, still recruiting):

Blood vessel spasm disorders: Raynaud's syndrome, scleroderma, acrocyanosis
Narrowed or blocked arteries in the arm, or a past clot or tear in the radial artery at the wrist
Artery inflammation such as Buerger's disease
Inflammatory joint disease: rheumatoid arthritis, psoriatic arthritis, crystal arthritis
Severe kidney disease, dialysis or a kidney transplant
Contrast dye allergy
Pregnancy or breastfeeding

Raynaud's and scleroderma deserve a plain statement. They appear only as exclusion criteria in that trial registration. No study has reported how people with these conditions do after hand embolization, good or bad. The caution makes sense, because the treatment is designed to briefly slow blood flow in a hand whose small arteries already tend to clamp down, but it is a precaution, not a proven finding.

One more point is specific to the drug. Nearly all published hand cases used imipenem/cilastatin, an antibiotic in the beta-lactam family, used off-label as a short-acting embolic. Its FDA label lists hypersensitivity to any component as a contraindication. Tell the doctor about any penicillin, cephalosporin or carbapenem allergy.

When another treatment is the better path

If you have not tried the basics. The American College of Rheumatology's 2026 update strongly recommends topical and oral anti-inflammatory medicines for hand osteoarthritis. It conditionally recommends hand exercise, splints (orthoses) for the thumb base and finger joints, and steroid injections, and advises referral to occupational therapy when hand use is limited. Unlike embolization, these are in the guidelines. See hand arthritis treatment without surgery.

If your arthritis is inflammatory or erosive. Rheumatoid and psoriatic arthritis are treated with specialized medicines by a rheumatologist. One published study excluded rheumatoid arthritis, and a registered French trial excludes rheumatoid, psoriatic and crystal arthritis. For erosive hand osteoarthritis, the 2026 update conditionally recommends methotrexate. A rheumatology opinion comes first.

If the joint is badly damaged and your hand no longer works for daily tasks. Surgery is the established option for a thumb base or finger joint that is extensively damaged. The American Academy of Orthopaedic Surgeons says full recovery after thumb base surgery takes several months, so it is a real commitment, but no study has compared it with embolization. A hand surgeon's opinion is worth having. Our comparison of embolization, injections and surgery lays out the trade-offs.

If stiffness or deformity bothers you more than pain. In the 2024 Taiwan study, stiffness did not change significantly at any time point.

What an evaluation involves

A candidacy visit typically covers:

Your history: which joints hurt, for how long, what you have tried and for how long.
An exam of the hand and of the pulses and circulation at the wrist. In the 2024 Taiwan study, a bedside circulation test was done before every procedure.
A review of hand X-rays to confirm osteoarthritis and its stage.
A review of allergies (antibiotics and contrast dye in particular), kidney health, medicines, and any history of Raynaud's or circulation problems in the hands.

Sometimes the right result is a referral to a hand therapist, a rheumatologist or a hand surgeon. That is a useful outcome, not a failed visit. Sudden new swelling, redness or warmth in a joint should be checked by a doctor promptly before any embolization planning, because other kinds of arthritis can look like this and are treated differently.

Questions to bring

Is my pain from osteoarthritis, and how sure are you?
Have I tried enough standard care, or is there a step I skipped?
Which of my joints would you treat, and which embolic agent do you use?
Does anything in my history, such as Raynaud's or a drug allergy, change the plan?
How many sessions should I expect, and what happens if it does not help?
How will my insurance treat this? The office verifies benefits before treatment.

For how embolization is used in other joints, see our embolization guide.

Frequently Asked Questions

Can I have hand embolization if I have Raynaud's?

A French safety trial lists Raynaud's syndrome and scleroderma as exclusion criteria, and no published study reports outcomes in people with these conditions. That is a precaution written into a trial, not a proven contraindication, so it needs an individual discussion with the doctor.

Does hand embolization work for rheumatoid arthritis?

There are no data. The published studies enrolled osteoarthritis only, and at least one study and one registered trial excluded rheumatoid and other inflammatory arthritis.

Do I need to try splints or injections first?

In the studies that state their entry rules, patients had at least 3 months of conservative treatment that had not controlled their pain. Guidelines recommend anti-inflammatory medicines, splints and exercise for hand osteoarthritis, list steroid injections as a conditional option and do not mention embolization.

Is there an age limit?

No upper age limit appears in the study summaries we could read. One study required patients to be at least 40, and the mean age in the largest series of 92 patients was 55.

Can it be done if I am allergic to penicillin?

The drug used in nearly all published hand studies is imipenem/cilastatin, a beta-lactam antibiotic, and one study excluded people with antibiotic allergy. Tell the doctor about any antibiotic allergy before an evaluation goes further.

Keep Reading

Sources

Medically reviewed by David Fox, MD, FACS, RPVI. This article is general information, not a substitute for a medical evaluation.

Living with joint or tendon pain that hasn’t improved? Schedule a consultation with Dr. David Fox at Fox Vein & Vascular in Manhattan to find out whether embolization is right for you. Call (212) 362-3470 or request an appointment online.

Hand Arthritis Embolization: Am I a Candidate?